Clindamycin Laurate
| CAS No. | : 763863-68-9 |
| Mol F. | : C30H55ClN2O6S |
| Mol W. | : 607.29 |
| Cat No. | : SA29703 |
- Description
- Quick Enquiry / RFQ
Description
| Product Name | Clindamycin Laurate |
| Synonyms | (2S-trans)-Methyl 7-Chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-L-threo-α-D-galacto-octopyranoside 2-Dodecanoate
(2R,5S)-6-[(2S)-1-{[(2S,4R)-1-Methyl-4-propyl-2-pyrrolidinyl]carbonylamino}-2-chloropropyl]-4,5-dihydroxy-2-(methylsulfinyl)tetrahydro-2H-pyran-3-yl dodecanoate |
| Related API | Clindamycin |
| Category | Impurities |
Clindamycin Laurate product with CAS: 763863-68-9 is also known as (2S-trans)-Methyl 7-Chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-L-threo-α-D-galacto-octopyranoside 2-Dodecanoate. This product can be used as a working standard or secondary reference standard. Additional internal validation as per respective FDA regulations/guidelines may require. Clindamycin Laurate is generally used for Quality Control (QC), Quality Assurance (QA) during commercial production of Clindamycin and its related formulations. Moreover, (2S-trans)-Methyl 7-Chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-L-threo-α-D-galacto-octopyranoside 2-Dodecanoate is also used in the process of Abbreviated New Drug Application (ANDA) filing to FDA and toxicity study of respective drug formulation.
If you need different pack size / quantity, please contact us or email us at [email protected]
